A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Clinical Editorial

Official title: A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Summary: This is a non-interventional, prospective, post authorization safety study. Patients with gMG who are expected to start treatment with efgartigimod at enrolment or are within their first cycle of efgartigimod at enrolment will be eligible to enroll into the efgartigimod cohort. Patients with gMG who have not been exposed to efgartigimod and for whom it is not planned to start treatment with efgartigimod at enrolment will be eligible to enroll into the non-efgartigimod cohort.

Conditions: Myasthenia Gravis

Study type: OBSERVATIONAL

Enrollment: 680 (ESTIMATED)

Status: RECRUITING

Completion: 2034-06 (ESTIMATED)

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT06298565

Open Original Source More Feed Items

Related by Condition/Drug

PLOS ONERelated by Specialty

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Clinical Briefing

Clinical Editorial

Source Reference

Related by Condition/Drug

Proteomic profiling of adult Fasciola gigantica from naturally infected buffaloes in Punjab, Pakis

Clogmia albipunctata unlikely to cause true intestinal myiasis: in vitro and in vivo evidence

WHO and Peking University announce collaboration on health emergency preparedness

FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know

Direct-to-participant double-blind trial for Long COVID: design and early operational insights

Event Annotation Framework for Post‑Acute Infection Syndromes in Dutch Primary Care